India Neurovascular Devices Market, By Device (Cerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices, Trans Radial Access Devices), By Therapeutic Application (Stroke, Cerebral Artery, Cerebral Aneurysm, Others), By End User (Hospitals, Specialty Clinics, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Market Overview

India Neurovascular Devices Market was valued at USD 202.95 Million in 2024 and is expected to reach USD 322.43 Million by 2030 with a CAGR of 7.98%. The India Neurovascular Devices Market is entering a phase of strategic acceleration, underpinned by the sharp rise in cerebrovascular conditions particularly stroke which now rank among the leading causes of mortality and long-term disability nationwide. This evolving disease landscape is driving sustained demand for advanced, minimally invasive neuro-interventional solutions, reshaping both clinical practices and procurement strategies across major healthcare institutions.

India’s market is approaching a structural pivot, where clinical urgency, technological progress, and rising procedural volumes are converging. The increasing preference for device-based stroke interventions, such as thrombectomy and coil embolization, is prompting hospitals to expand neuro-interventional capacity and invest in high-precision devices and imaging platforms. However, barriers around cost sensitivity, uneven geographic access, and limited neurology-trained professionals continue to constrain full-scale adoption.

Despite these systemic limitations, momentum is built driven by a combination of public and private capital investments, growing insurance coverage through programs like Ayushman Bharat, and the expansion of stroke-ready centers in tier-1 and tier-2 cities. These developments are setting the stage for robust mid- to long-term market expansion, positioning India as a strategic growth hub for global neurovascular device manufacturers seeking scalable opportunities in high-burden emerging markets.

Key Market Drivers

Increasing Prevalence of Neurological Disorders, Especially Stroke

The growing prevalence of neurological disorders particularly stroke acts as a foundational market driver for the India Neurovascular Devices Market. Neurological disorders have emerged as a critical public health issue in India, with prevalence estimates ranging between 3.0 and 11.9 cases per 1,000 individuals. This growing burden reflects a concerning trend in both urban and rural populations, placing sustained pressure on the country's healthcare infrastructure and significantly increasing the demand for specialized neurological interventions and technologies. India has witnessed a dramatic surge in stroke incidence over the past three decades. According to a recent study published in The Lancet Neurology, the number of new stroke cases rose from approximately 650,000 in 1990 to over 1.25 million in 2021, marking a 51% increase. This increase is being driven by widespread risk factors, including Hypertension, Diabetes and metabolic syndrome, Tobacco and alcohol consumption, Sedentary lifestyles, Increased life expectancy and aging population. Crucially, strokes are no longer confined to the elderly. Middle-aged and younger adults, particularly in urban and semi-urban areas, are increasingly affected. This shift has made neurovascular disorders a public health emergency, demanding scalable medical responses. The rise in stroke cases directly translates into higher procedural volumes for mechanical thrombectomy, coil embolization, stenting, and aspiration techniques driving greater utilization of neurovascular devices such as stent retrievers, flow diverters, and microcatheters.

With greater emphasis on the “golden hour” in stroke treatment, there is a paradigm shift toward fast-track diagnosis and interventional management. Clinical guidelines increasingly recommend the use of neurovascular devices as first-line treatments for eligible patients with large vessel occlusions or aneurysms. This change in clinical practice is boosting the demand for advanced devices that enable minimally invasive, time-sensitive procedures. Hospitals are now prioritizing the acquisition of thrombectomy kits, neurostents, and coil systems to meet the growing caseload. As the stroke burden rises, healthcare providers particularly in metro and tier-1 cities are under growing pressure to establish or upgrade stroke units, neurology departments, and interventional radiology suites. The increasing prevalence of neurological events is prompting both public and private hospitals to invest in state-of-the-art neurovascular technologies.

This investment trend is creating a scalable infrastructure base for neurovascular devices, with hospitals actively seeking vendors, training, and inventory support. It also opens doors for long-term service contracts and recurring revenue models for device manufacturers and suppliers. Due to greater media coverage, public health campaigns, and community education efforts, patients and caregivers are becoming more aware of stroke symptoms and the importance of seeking emergency medical intervention. This awareness is leading to: Faster hospital arrivals, Increased demand for device-based treatment pathways, Higher acceptance of interventional procedures over traditional surgical options. Early presentation of stroke cases improves eligibility for device-based interventions, thereby increasing the addressable patient pool for neurovascular product utilization.

Increased Awareness and Early Diagnosis Among Patients and Physicians

The increasing awareness of neurovascular conditions particularly stroke and advancements in early diagnosis are playing a pivotal role in accelerating the growth of the India Neurovascular Devices Market. These shifts are reshaping patient behavior, clinical response patterns, and hospital decision-making, leading to a higher demand for sophisticated, minimally invasive neuro-interventional devices. Over the past few years, awareness campaigns led by healthcare organizations, NGOs, and government bodies have made substantial progress in educating the Indian population about the warning signs of stroke, such as: Facial drooping, Sudden weakness on one side, Slurred speech, Vision loss or imbalance. Initiatives such as the promotion of the FAST (Face, Arm, Speech, Time) protocol have gained traction, particularly in urban and semi-urban areas. With increased recognition of symptoms, more patients are now seeking care within the critical “golden hour”, when device-based interventions such as mechanical thrombectomy or stent placement are most effective. This shift is directly expanding the eligible patient population for neurovascular procedures and driving up demand for related devices.

There is a growing emphasis on continuing medical education (CME) for neurologists, emergency physicians, and interventional radiologists across India. Leading healthcare institutions also implementing standardized clinical pathways for the diagnosis and management of neurovascular emergencies. As physicians become more confident and better trained in using interventional neurovascular techniques, the frequency of device-guided procedures is increasing. Additionally, doctors are more likely to adopt advanced tools such as flow diverters, aspiration catheters, and coil embolization systems, which are essential to modern stroke and aneurysm management. Technological upgrades in radiology, including the wider availability of CT angiography, MRI, and perfusion imaging, are enabling faster and more accurate detection of cerebrovascular abnormalities. AI-enabled imaging platforms and integrated hospital systems are also reducing the time from diagnosis to intervention. Improved diagnostics mean that more patients are diagnosed early and correctly, leading to timely referrals for interventional procedures. This directly increases the consumption of neurovascular devices, as faster diagnoses translate to higher procedural conversion rates.

As awareness improves, more patients and their families understand the benefits of minimally invasive neurovascular procedures including shorter hospital stays, reduced risk of complications, and faster recovery compared to open surgery. This shift in patient mindset is improving procedural acceptance and driving hospital procurement of advanced neuro-interventional tools. Hospitals are responding to this growing preference by investing in neurovascular devices, expanding neuro-interventional services, and training staff contributing to sustained demand growth across both public and private sectors.

Download Free Sample Report

Key Market Challenges

High Cost of Neurovascular Devices and Limited Insurance Coverage

Neurovascular devices such as stent retrievers, embolization coils, flow diverters, and thrombectomy catheters are capital-intensive technologies. Most of these are imported, leading to higher acquisition costs, which are ultimately passed on to the patients.

A single neuro-interventional procedure can cost between INR 3–10 lakhs, making it unaffordable for a vast segment of India’s population, especially in the absence of comprehensive insurance coverage. Most government health schemes offer limited reimbursement for complex neurovascular procedures, while private insurance penetration remains low or restrictive on coverage for advanced interventions. This cost barrier significantly narrows the addressable market, with only high-income or insured urban patients able to access the latest device-based treatments.

Uneven Distribution of Skilled Neurological Workforce and Infrastructure

India suffers from a severe shortage of trained interventional neurologists, neurosurgeons, and radiologists, particularly outside metro cities. Advanced neurovascular procedures require not only skilled professionals but also dedicated stroke units, hybrid operating rooms, and high-resolution neuroimaging systems resources that are scarce in many public hospitals and tier-2/tier-3 cities.

As a result, a large percentage of stroke and aneurysm patients are either misdiagnosed, referred late, or treated without access to life-saving device-based interventions. This geographic and skill-based disparity slows down the overall procedural volume growth. Unless medical training, infrastructure investment, and technology transfer are significantly scaled, the full diffusion of neurovascular technologies will remain limited to a few elite centers.

Key Market Trends

Expansion of Neuro-Interventional Infrastructure in Tier 2 and Tier 3 Cities

Historically, neurovascular procedures in India have been concentrated in top-tier private hospitals in metropolitan areas. However, recent years have seen a decentralization of neurological care, with public and private stakeholders expanding interventional infrastructure into emerging urban clusters and state-level medical colleges.

Leading healthcare providers and hospital chains are investing in stroke units, advanced neuroimaging equipment, and interventional radiology suites in secondary cities. This is increasing the installed base for neurovascular devices and enhancing geographic access to critical neurological care. As awareness and clinical training spread, and device manufacturers form partnerships with regional hospitals, device penetration in semi-urban India is expected to multiply, tapping into a previously under-served patient population.

Technological Advancements and Growing Domestic Manufacturing

Innovation in neurovascular device technology is transforming treatment protocols. The market is witnessing the introduction of next-generation materials, enhanced catheter flexibility, microcatheters for deep vessel access, and precision-guided navigation systems. Additionally, India is beginning to witness growth in local manufacturing and R&D, supported by government initiatives such as ‘Make in India’ and the PLI scheme for medical devices.

These advancements are improving clinical outcomes, procedural efficiency, and reducing overall treatment costs. Domestic manufacturing is also improving supply chain reliability and enabling more cost-effective pricing models tailored to Indian hospitals. As Indian manufacturers scale operations and global players expand their R&D footprints in India, the country is likely to emerge not just as a consumption hub, but also as a manufacturing and export base for neurovascular technologies.

Segmental Insights

Therapeutic Application Insights

Based on the category of Therapeutic Application, the Stroke segment emerged as the fastest growing segment in the India Neurovascular Devices Market in 2024. India is witnessing a sharp increase in both ischemic and hemorrhagic strokes, driven by lifestyle-related risk factors such as hypertension, diabetes, sedentary habits, and poor dietary patterns. Notably, strokes are increasingly affecting younger populations, particularly in urban and semi-urban regions. This epidemiological shift is pushing the demand for timely and effective neurovascular interventions.

Several Indian states, along with the central government, are prioritizing stroke as a public health emergency. Initiatives under programs like the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) are enhancing early screening, diagnosis, and emergency response infrastructure creating a conducive environment for device-based stroke management. The introduction and widespread clinical adoption of mechanical thrombectomy, stent retrievers, aspiration catheters, and balloon occlusion devices have revolutionized stroke care. These technologies allow for minimally invasive procedures with faster recovery and reduced morbidity. Major hospitals in metro and tier-1 cities are rapidly equipping neuro-interventional departments to manage acute stroke cases effectively. These factors are expected to drive the growth of this segment.

Download Free Sample Report

Regional Insights

South India emerged as the largest market in the India Neurovascular Devices Market in 2024, holding the largest market share in terms of value. South India, particularly cities like Bengaluru, Chennai, Hyderabad, and Kochi, hosts a significant number of multi-specialty hospitals, tertiary care centers, and neurology-focused institutes. These healthcare hubs are well-equipped with state-of-the-art neuro-interventional radiology and neurosurgical infrastructure, enabling faster adoption of advanced neurovascular devices such as coiling systems, stent retrievers, and flow diverters. The region is home to several high-volume centers of excellence in neurology and interventional neuroradiology. Moreover, South India has a strong presence of trained neurologists, interventional radiologists, and neurosurgeons, many of whom participate in clinical trials, device evaluations, and early adoption of next-gen technologies further driving regional demand.

Cities like Chennai and Bengaluru attract a significant number of domestic and international medical tourists seeking advanced neuro-interventions, particularly for stroke management, aneurysms, and arteriovenous malformations (AVMs). This influx sustains high procedure volumes and supports continuous procurement and utilization of neurovascular devices. The literacy rate, health awareness, and early diagnosis levels are comparatively higher in South India. This leads to early referrals and timely intervention in neurological cases such as ischemic stroke, thereby increasing the procedural volumes that require neurovascular devices.

Recent Developments

• In November 2024- Philips India has launched its next-generation Azurion interventional platform, targeting specialists across neurology, cardiology, vascular, and surgical disciplines. Engineered to optimize workflow efficiency in complex neurovascular procedures, the system integrates advanced C-arm rotation and enhanced angulation capabilities, enabling precise imaging from multiple angles. The platform is designed to support care teams in accelerating clinical decision-making, increasing procedural throughput, and improving patient outcomes positioning it as a high-value solution in India’s rapidly evolving interventional care landscape.

Key Market Players

• Stryker
• Medtronic
• Terumo India Private Limited
• Medical Device Business Services, Inc
• Penumbra, Inc.
• B. Braun SE
• Integra LifeSciences Corporation
• Acandis India Pvt. Ltd
• MicroPort Scientific Corporation

Report Scope:

In this report, the India Neurovascular Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• India Neurovascular Devices Market, By Device:

o   Cerebral Embolization and Aneurysm Coiling Devices

o   Cerebral Angioplasty and Stenting Systems

o   Neurothrombectomy Devices

o   Support Devices

o   Trans Radial Access Devices

• India Neurovascular Devices Market, By Therapeutic Application:

o   Stroke

o   Cerebral Artery

o   Cerebral Aneurysm

o   Others

• India Neurovascular Devices Market, By Therapeutic End User:

o   Hospitals

o   Specialty Clinics

o   Others

• India Neurovascular Devices Market, By Region:

o   North India

o   East India

o   West India

o   South India

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the India Neurovascular Devices Market.

Available Customizations:

 India Neurovascular Devices market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).